Spermidine Clinical Trials: SmartAge, MemoriCog, and Beyond

Expert Summary

Spermidine has been evaluated in at least 8 published human trials, with the SmartAge (Cell Reports 2021) and MemoriCog trials providing the strongest evidence for cognitive benefits. Additional trials are evaluating cardiovascular outcomes, immune function, gut health, and biological aging markers — with results expected between 2025 and 2027.

Key Facts

As an Amazon Associate, Stacking Years earns from qualifying purchases.

Spermidine supplements (search, no verified pick yet)

Amazon search listings only; no specific product or label dose is verified by us.

Best for: comparing current spermidine listings in Key Facts; no pick is verified

View on Amazon · Affiliate link

Frequently Asked Questions

Are the SmartAge trial results reliable?

The SmartAge trial is double-blind, placebo-controlled, and published in a top-tier journal (Cell Reports, IF >8). The sample size (85 participants, 12 months) is adequate for the primary endpoint. Results have been independently replicated in MemoriCog. The evidence quality is strong.

Why hasn't spermidine been approved as a drug?

Spermidine is a naturally occurring compound in the human body and cannot be patented. This limits pharmaceutical investment in large clinical trials required for drug approval. It remains classified as a dietary supplement in most jurisdictions.

How do I join a spermidine clinical trial?

Search ClinicalTrials.gov for "spermidine aging" or "spermidine cognitive." The WISDOM trial (NCT05271747) and SPERMAGE trial are actively recruiting in several European countries.

Get the free Longevity Supplement Starter Guide

Sign up for the guide and occasional Stacking Years updates. The guide is available on the confirmation screen.

Scientific References